Skip to main navigation Skip to search Skip to main content

Papillary serous carcinoma in situ in ovarian endometriosis in an MSH2 mutation carrier

  • Zvi Vaknin
  • , Walter H. Gotlieb
  • , Jocelyne Arseneau
  • , Alex Ferenczy*
  • *Corresponding author for this work
  • McGill University
  • Jewish General Hospital

Research output: Contribution to journalArticlepeer-review

2 Scopus citations
Original languageEnglish
Pages (from-to)68-69
Number of pages2
JournalInternational Journal of Gynecology and Obstetrics
Volume107
Issue number1
DOIs
StatePublished - Oct 2009
Externally publishedYes

Funding

Funders
American Physicians Fellowship
Israel Cancer Research Fund
Israel Cancer Association
Sackler Faculty of Medicine, Tel-Aviv University

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Endometriosis
    • Hereditary nonpolyposis colorectal cancer (HNPCC)
    • Lynch syndrome
    • Ovarian cancer
    • Prophylactic surgery
    • Serous carcinoma in situ

    Cite this